BR9710993A - Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als) - Google Patents
Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als)Info
- Publication number
- BR9710993A BR9710993A BR9710993-2A BR9710993A BR9710993A BR 9710993 A BR9710993 A BR 9710993A BR 9710993 A BR9710993 A BR 9710993A BR 9710993 A BR9710993 A BR 9710993A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- als
- amyotrophic lateral
- lateral sclerosis
- derivatives useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Patente de Invenção: "PROCESSO PARA TRATAMENTO DE ESCLEROSE LATERAL AMIOTRóFICA (ALS)". São descritos derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (ais).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2200696P | 1996-06-28 | 1996-06-28 | |
PCT/US1997/010955 WO1998000131A1 (en) | 1996-06-28 | 1997-06-24 | Anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (als) |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9710993A true BR9710993A (pt) | 2002-02-26 |
Family
ID=21807346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9710993-2A BR9710993A (pt) | 1996-06-28 | 1997-06-24 | Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als) |
Country Status (22)
Country | Link |
---|---|
US (1) | US5753694A (pt) |
EP (1) | EP0936908B1 (pt) |
JP (1) | JP2000514426A (pt) |
AP (1) | AP1167A (pt) |
AT (1) | ATE214274T1 (pt) |
AU (1) | AU725093B2 (pt) |
BR (1) | BR9710993A (pt) |
CA (1) | CA2258892C (pt) |
CZ (1) | CZ293945B6 (pt) |
DE (1) | DE69711067T2 (pt) |
DK (1) | DK0936908T3 (pt) |
ES (1) | ES2176755T3 (pt) |
HU (1) | HUP9904318A3 (pt) |
IL (1) | IL127717A (pt) |
NO (1) | NO317136B1 (pt) |
NZ (1) | NZ333588A (pt) |
PT (1) | PT936908E (pt) |
SI (1) | SI0936908T1 (pt) |
SK (1) | SK284331B6 (pt) |
UA (1) | UA46112C2 (pt) |
WO (1) | WO1998000131A1 (pt) |
ZA (1) | ZA975764B (pt) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985930A (en) * | 1996-11-21 | 1999-11-16 | Pasinetti; Giulio M. | Treatment of neurodegenerative conditions with nimesulide |
US6583172B1 (en) | 1999-04-08 | 2003-06-24 | Richard P. Shank | Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
US7553818B2 (en) * | 1999-06-14 | 2009-06-30 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
US7056890B2 (en) | 1999-06-14 | 2006-06-06 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
US20080255093A1 (en) * | 1999-06-14 | 2008-10-16 | Tam Peter Y | Compositions and methods for treating obesity and related disorders |
US7659256B2 (en) * | 1999-06-14 | 2010-02-09 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
US7674776B2 (en) | 1999-06-14 | 2010-03-09 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
DE60035870T2 (de) | 1999-06-14 | 2008-05-08 | Vivus Inc., Mountain View | Kombinationstherapie zur gewichtsreduzierung und fettleibigkeitsbehandlung |
US20080103179A1 (en) * | 2006-10-27 | 2008-05-01 | Tam Peter Y | Combination Therapy |
US6191117B1 (en) * | 2000-07-10 | 2001-02-20 | Walter E. Kozachuk | Methods of producing weight loss and treatment of obesity |
CA2430010A1 (en) | 2000-11-30 | 2002-06-06 | University Of Florida | Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
JP2005501801A (ja) * | 2001-02-02 | 2005-01-20 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | フラクトピラノーススルファメートとエリスロポイエチンを含んで成る神経学的機能不全治療 |
WO2003041697A1 (en) * | 2001-11-14 | 2003-05-22 | Ralph Ryback | Method for treating autoimmune diseases |
US20060041022A1 (en) * | 2002-11-06 | 2006-02-23 | Pasinetti Giulio M | Treatment of amyotrophic lateral sclerosis with nimesulide |
CA2505514A1 (en) * | 2002-11-06 | 2004-05-27 | Mount Sinai School Of Medicine | Treatment of amyotrophic lateral sclerosis with nimesulide |
US20050070524A1 (en) * | 2003-06-06 | 2005-03-31 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders |
MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
MX2007002309A (es) * | 2004-08-24 | 2007-10-08 | Johnson & Johnson | Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos. |
IS7748A (is) * | 2005-03-17 | 2006-09-18 | Actavis Group | Samsetning fyrir töflur sem innihalda topiramate |
JP2008545650A (ja) * | 2005-05-20 | 2008-12-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルファミド誘導体の製造方法 |
US20070155823A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
US20070155827A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
US8497298B2 (en) * | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8691867B2 (en) * | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8492431B2 (en) * | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US8716231B2 (en) * | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US20070155824A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis |
US8937096B2 (en) * | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US20070191474A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine |
US20070191451A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents |
US20070191460A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis |
TW200812573A (en) * | 2006-05-19 | 2008-03-16 | Janssen Pharmaceutica Nv | Co-therapy for the treatment of epilepsy and related disorders |
FR2903019A1 (fr) * | 2006-06-30 | 2008-01-04 | Univ Claude Bernard Lyon I Eta | Utilisation d'un inhibiteur de l'anhydrase carbonique, pour la preparation d'un medicament destine a traiter des degenerescences du muscle squelettique |
US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
US20090247616A1 (en) * | 2008-03-26 | 2009-10-01 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety |
US20090304789A1 (en) | 2008-06-09 | 2009-12-10 | Thomas Najarian | Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders |
US8580298B2 (en) | 2008-06-09 | 2013-11-12 | Vivus, Inc. | Low dose topiramate/phentermine composition and methods of use thereof |
MX2011000090A (es) | 2008-06-23 | 2011-03-02 | Janssen Pharmaceutica Nv | Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]diox in-2-ilmetil)sulfamida. |
US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US4792569A (en) * | 1987-08-27 | 1988-12-20 | Mcneilab, Inc. | Anticonvulsant phenethyl sulfamates |
US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
-
1997
- 1997-06-23 US US08/881,023 patent/US5753694A/en not_active Expired - Fee Related
- 1997-06-24 SI SI9730259T patent/SI0936908T1/xx unknown
- 1997-06-24 WO PCT/US1997/010955 patent/WO1998000131A1/en active IP Right Grant
- 1997-06-24 CZ CZ19984279A patent/CZ293945B6/cs not_active IP Right Cessation
- 1997-06-24 BR BR9710993-2A patent/BR9710993A/pt not_active Application Discontinuation
- 1997-06-24 DE DE69711067T patent/DE69711067T2/de not_active Expired - Fee Related
- 1997-06-24 ES ES97931367T patent/ES2176755T3/es not_active Expired - Lifetime
- 1997-06-24 AU AU35010/97A patent/AU725093B2/en not_active Ceased
- 1997-06-24 HU HU9904318A patent/HUP9904318A3/hu unknown
- 1997-06-24 DK DK97931367T patent/DK0936908T3/da active
- 1997-06-24 AT AT97931367T patent/ATE214274T1/de not_active IP Right Cessation
- 1997-06-24 IL IL12771797A patent/IL127717A/en not_active IP Right Cessation
- 1997-06-24 SK SK1806-98A patent/SK284331B6/sk unknown
- 1997-06-24 NZ NZ333588A patent/NZ333588A/xx unknown
- 1997-06-24 JP JP10504245A patent/JP2000514426A/ja active Pending
- 1997-06-24 EP EP97931367A patent/EP0936908B1/en not_active Expired - Lifetime
- 1997-06-24 PT PT97931367T patent/PT936908E/pt unknown
- 1997-06-24 AP APAP/P/1998/001428A patent/AP1167A/en active
- 1997-06-24 UA UA98126945A patent/UA46112C2/uk unknown
- 1997-06-24 CA CA002258892A patent/CA2258892C/en not_active Expired - Fee Related
- 1997-06-27 ZA ZA975764A patent/ZA975764B/xx unknown
-
1998
- 1998-12-22 NO NO19986054A patent/NO317136B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
AP1167A (en) | 2003-06-30 |
SK284331B6 (sk) | 2005-01-03 |
DK0936908T3 (da) | 2002-05-27 |
WO1998000131A1 (en) | 1998-01-08 |
US5753694A (en) | 1998-05-19 |
HUP9904318A3 (en) | 2001-02-28 |
CA2258892A1 (en) | 1998-01-08 |
PT936908E (pt) | 2002-08-30 |
DE69711067T2 (de) | 2002-09-19 |
AU725093B2 (en) | 2000-10-05 |
NO986054L (no) | 1999-03-01 |
CZ427998A3 (cs) | 1999-08-11 |
EP0936908B1 (en) | 2002-03-13 |
CA2258892C (en) | 2005-08-09 |
JP2000514426A (ja) | 2000-10-31 |
NO986054D0 (no) | 1998-12-22 |
HUP9904318A2 (hu) | 2000-05-28 |
SK180698A3 (en) | 2000-07-11 |
ZA975764B (en) | 1998-12-28 |
UA46112C2 (uk) | 2002-05-15 |
IL127717A (en) | 2004-09-27 |
NO317136B1 (no) | 2004-08-23 |
IL127717A0 (en) | 1999-10-28 |
ATE214274T1 (de) | 2002-03-15 |
EP0936908A1 (en) | 1999-08-25 |
AP9801428A0 (en) | 1998-12-31 |
CZ293945B6 (cs) | 2004-08-18 |
SI0936908T1 (en) | 2002-12-31 |
NZ333588A (en) | 2000-07-28 |
AU3501097A (en) | 1998-01-21 |
DE69711067D1 (de) | 2002-04-18 |
ES2176755T3 (es) | 2002-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9710993A (pt) | Derivados anticonvulsivos úteis no tratamento de esclerose lateral amiotrófica (als) | |
BR9710994A (pt) | Derivados anticonvulsivos úteis no tratamento de obesidade. | |
BR9808491A (pt) | Compostos calcilìticos | |
BR9712783A (pt) | Derivados anticonvulsivos úteis no tratamento de doença bipolar manìaco-depressiva | |
ATE167670T1 (de) | N-alkylthiopolyaminderivate als radioprotektive mittel | |
BR9610909A (pt) | Composição oxidante processo de tratamento das matérias queratínicas e processo de descoloração das matérias queratínicas | |
FR2718351B1 (fr) | Procédé pour la déformation permanente des matières kératiniques. | |
FR2707486B1 (fr) | Procédé de déformation permanente des matières kératiniques. | |
BR9606678A (pt) | Processo de metalurgia | |
IL122606A0 (en) | (S)-hydroxy-nitrile-lyase | |
BR9404156A (pt) | Processo para purificação de indigo | |
BR9914722A (pt) | Derivados de anticonvulsivo úteis no tratamento de dependência, vìcio e abuso do álcool | |
BR9710992A (pt) | Derivados anticovulsivos úteis no tratamento de psorìase | |
IT235831Y1 (it) | "calzatoia per veicoli industriali" | |
IT1282294B1 (it) | Coppia di cilindri strappatori. | |
FR2701573B1 (fr) | Monture de lunettes. | |
ITBO970316A0 (it) | Metodo e macchina per l'assemblaggio di riduttori. | |
FR2716803B1 (fr) | Procédé pour la déformation permanente des matières kératiniques. | |
ITTO940505A0 (it) | Procedimento per l'attuazione di microgiunti e macchina per l'attuazione di tale procedimento. | |
MX9602767A (es) | Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina. | |
BR9709766A (pt) | Processo de preparação de 2,2'-(1-metil-1,2-etanodilideno)bis(hidrazina carboximidamida) | |
IT1292007B1 (it) | Processo per la preparazione di hcfc-123 | |
BR9712805A (pt) | Processo para a preparação de compostos farmecêuticos | |
ITMI951830A0 (it) | Processo per la lavorazione di pelli | |
FR2714994B1 (fr) | Ensemble de composition de codes d'identification, notamment pour câbles. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE INCIDE NO ART. 10 ( VIII ) DA LPI |